Federal Register / Vol. 89, No. 37 / Friday, February 23, 2024 / Notices 13745 

Controlled substance Drug 

code Schedule 

Ecgonine .......................... 9180 II 

The company plans to produce the 

listed controlled substance in bulk to be 

used in the manufacture of the DEA 

exempt products. No other activities for 

this drug code is authorized for this 

registration. 

Marsha Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–03712 Filed 2–22–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1323] 

Importer of Controlled Substances 

Application: Meridian Medical 

Technologies, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Meridian Medical 

Technologies, LLC has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 25, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before March 25, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 17, 2024, 

Meridian Medical Technologies, LLC, 

2555 Hermelin Drive, Saint Louis, 

Missouri 63144, applied to be registered 

as an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Morphine .......................... 9300 II 

The company plans to import the 

listed controlled substances for 

analytical purposely only. No other 

activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Marsha Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–03714 Filed 2–22–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1318] 

Importer of Controlled Substances 

Application: Pall Life Sciences PR, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Pall Life Sciences PR, LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 25, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before March 25, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 11, 2024, Pall 

Life Sciences PR, LLC, Road 194, 

Kilometer 0.4, Fajardo, Puerto Rico 

00738, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Morphine .......................... 9300 II 

The company plans to import the 

listed controlled substances for research 

purposes, drug testing, and analysis to 

support foreign regulatory compliance 

of finished dosage forms to foreign 

markets. No other activities for these 

drug codes are authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonVerDate Sep<11>2014 17:19 Feb 22, 2024 Jkt 262001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\23FEN1.SGM 23FEN1

ddrumheller on DSK120RN23PROD with NOTICES1

I I 

I I 

I I 
13746 Federal Register / Vol. 89, No. 37 / Friday, February 23, 2024 / Notices 

approved finished dosage forms for 

commercial sale. 

Marsha Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–03683 Filed 2–22–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1326] 

Importer of Controlled Substances 

Application: S&B Pharma LLC DBA 

Norac Pharma 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: S&B Pharma LLC DBA Norac 

Pharma has applied to be registered as 

an importer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 25, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before March 25, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 10, 2024, S&B 

Pharma LLC DBA Norac Pharma, 405 

South Motor Avenue, Azusa, California 

91702, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

4-Anilino-N-phenethyl-4- 

piperidine (ANPP).

8333 II 

Tapentadol ..................... 9780 II 

The company plans to import 

intermediate forms of Tapentadol (9780) 

for further manufacturing prior to 

distribution to its customers. The 

company plans to import ANNP (8333) 

to bulk manufacture other controlled 

substances for distribution to its 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Marsha Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–03718 Filed 2–22–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1319] 

Bulk Manufacturer of Controlled 

Substances Application: Patheon API 

Services Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Patheon API Services Inc. has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before April 23, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before April 23, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on December 21, 2023, 

Patheon API Services Inc., 101 

Technology Place, Florence, South 

Carolina 29501, applied to be registered 

as a bulk manufacturer of the following 

basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Dimethyltryptamine ........ 7435 I 

Psilocybin ...................... 7437 I 

Psilocyn ......................... 7438 I 

Amphetamine ................ 1100 II 

Methadone ..................... 9250 II 

The company plans to bulk 

manufacture the above controlled 

substances to support customers’ 

clinical trials. No other activities for 

these drug codes are authorized for this 

registration. 

Marsha Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–03686 Filed 2–22–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1325] 

Importer of Controlled Substances 

Application: Pfizer, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Pfizer, Inc. has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplementary Information 


ddrumheller on DSK120RN23PROD with NOTICES1

I I